Ke Cao
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 32
- MicroRNA in disease regulation 16
- Cancer, Hypoxia, and Metabolism 10
- Oncology 30
Ke Cao
143 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 1.9k
- Oncology 1.2k
- Molecular Biology 2.9k
- Immunology 761
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Ke Cao
This map shows the geographic impact of Ke Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Cao more than expected).
Fields of papers citing papers by Ke Cao
This network shows the impact of papers produced by Ke Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Cao. The network helps show where Ke Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ke Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 5 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 18 | |
| 11 | 2021 | 61 | |
| 12 | The significance of exosomes in the development and treatment of hepatocellular carcinoma Hit paper breakdown → | 2020 | 394 |
| 13 | 2020 | 20 | |
| 14 | 2017 | 56 | |
| 15 | 2017 | 43 | |
| 16 | 2016 | 4 | |
| 17 | MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells. | 2014 | 42 |
| 18 | 2014 | 39 | |
| 19 | 2011 | 23 | |
| 20 | 2010 | 40 |
About Ke Cao
Ke Cao is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Dermatology, having authored 151 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (32 papers), RNA modifications and cancer (22 papers), Ferroptosis and cancer prognosis (20 papers), MicroRNA in disease regulation (16 papers), Cancer, Hypoxia, and Metabolism (10 papers), Circular RNAs in diseases (10 papers), Bladder and Urothelial Cancer Treatments (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (1.2k citations), Molecular Biology (2.9k citations), Immunology (761 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Ke Cao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianda Zhou, Wei Xiong, Xiayu Li, Guiyuan Li, Zhaoyang Zeng, Zhaojian Gong, Can Guo, Dong He, Yuxing Zhu and Yu Lian. Their work appears in journals such as Frontiers in Oncology, Oncogene, Frontiers in Immunology, Oncology Reports and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.